![Wim Ottevaere](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wim Ottevaere
Directeur/Membre du Conseil chez
SEQUANA MEDICAL N.V.
Profil
Wim Ottevaere is an Independent Non-Executive Director at Sequana Medical NV.
He previously worked as a Finance Director at Vanhout & Fils NV from 1990 to 1992, as the Chief Financial Officer at Fujirebio Europe NV from 1992 to 2006, as the Chief Financial Officer at Ablynx NV from 2006 to 2018, and as the Chief Financial Officer at Fujirebio US, Inc. from 1992 to 2006.
He is also currently serving as the Chief Financial Officer at Biotalys NV from 2020 to 2023.
Mr. Ottevaere graduated from the University of Antwerp.
Postes actifs de Wim Ottevaere
| Sociétés | Poste | Début |
|---|---|---|
| SEQUANA MEDICAL N.V. | Directeur/Membre du Conseil | 08/11/2018 |
Anciens postes connus de Wim Ottevaere
| Sociétés | Poste | Fin |
|---|---|---|
| BIOTALYS NV | Directeur Financier/CFO | 01/06/2023 |
| ABLYNX | Directeur Financier/CFO | 01/09/2018 |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Develops and markets diagnostic products to improve therapy management and patient health | Directeur Financier/CFO | 01/07/2006 |
Fujirebio US, Inc.
 Fujirebio US, Inc. Medical DistributorsDistribution Services The company is based in Alpharetta, GA. Founded in 1997, Fujirebio US, Inc. offers diagnostic tools including the Lumipulse® G ?-amyloid ratio (1-42/1-40) calculator tool, which assists users in interpreting results from the Lumipulse G ?-amyloid 1-42 and 1-40 immunoreaction cartridges according to specific instructions and recommended values. | Directeur Financier/CFO | 01/01/2006 |
Vanhout & Fils NV
 Vanhout & Fils NV HomebuildingConsumer Durables Provides building and structural construction services | Directeur Financier/CFO | 01/01/1992 |
Formation de Wim Ottevaere
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
45
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Develops and markets diagnostic products to improve therapy management and patient health | Health Technology |
Vanhout & Fils NV
Vanhout & Fils NV HomebuildingConsumer Durables Provides building and structural construction services | Consumer Durables |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
University of Antwerp
 University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fujirebio US, Inc.
Fujirebio US, Inc. Medical DistributorsDistribution Services The company is based in Alpharetta, GA. Founded in 1997, Fujirebio US, Inc. offers diagnostic tools including the Lumipulse® G ?-amyloid ratio (1-42/1-40) calculator tool, which assists users in interpreting results from the Lumipulse G ?-amyloid 1-42 and 1-40 immunoreaction cartridges according to specific instructions and recommended values. | Distribution Services |
Biotalys NV
 Biotalys NV Chemicals: AgriculturalProcess Industries Develops sustainable crop protection products | Process Industries |
Sequana Medical NV
 Sequana Medical NV Medical SpecialtiesHealth Technology Manufactures and distributes electro medical devices like alfa pump to remove excess fluid in patients with liver disease & heart failure | Health Technology |
